Composite Measures in Psoriatic Arthritis: GRAPPA 2008
Overview
Authors
Affiliations
At the 2008 annual meeting of GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) in Leeds, UK, members discussed the value and current status of composite measures for the assessment of psoriatic arthritis (PsA). In plenary presentations, examples of composite measures developed for rheumatoid arthritis (RA) and ankylosing spondylitis (AS) were reviewed, followed by a presentation of the assessment of disease activity in systemic lupus erythematosus. Three recently devised composite methods of assessing activity or response in PsA also were presented. Considerable discussion followed in breakout groups, and members agreed that a new composite measure specifically for PsA is necessary. The composite measure should include components that encompass the spectrum of psoriatic disease, i.e., in addition to assessment of peripheral joints, it should include assessment of sacroiliitis, spondylitis, enthesitis, and dactylitis, as well as skin and nail disease.
Urruticoechea-Arana A, Alvarez-Vega J, Garcia-Vivar M, Pinto-Tasende J, Garcia de Yebenes M, Carmona L Rheumatol Int. 2024; 44(11):2327-2336.
PMID: 38969942 DOI: 10.1007/s00296-024-05644-y.
Carneiro C, Chaves M, Verardino G, Frade A, Guimaraes Coscarelli P, Bianchi W Clin Cosmet Investig Dermatol. 2017; 10:155-163.
PMID: 28507445 PMC: 5428766. DOI: 10.2147/CCID.S124886.
Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control.
Furst D, Tran M, Sullivan E, Pike J, Piercy J, Herrera V Clin Rheumatol. 2017; 36(9):2045-2054.
PMID: 28238086 PMC: 5554474. DOI: 10.1007/s10067-017-3578-9.
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis.
Kingsley G, Kowalczyk A, Taylor H, Ibrahim F, Packham J, McHugh N Rheumatology (Oxford). 2012; 51(8):1368-77.
PMID: 22344575 PMC: 3397466. DOI: 10.1093/rheumatology/kes001.
Pontifex E, Gerlag D, Gogarty M, Vinkenoog M, Gibbs A, Burgman I Arthritis Res Ther. 2011; 13(1):R7.
PMID: 21272347 PMC: 3241351. DOI: 10.1186/ar3228.